Back to News

Access ISN-ACT Webinar on Hypoxia-inducible Factor-prolyl Hydroxylase Inhibitors

Did you miss the live session? A recording is available here.

Professor Meg Jardine, ISN-ACT (Advancing Clinical Trials) Committee chair, and speakers David Wheeler, Jonathan Barratt and Jodie Babitt joined in a lively discussion on this treatment option and on the management of anemia in CKD patients.

This webinar is supported by Astellas.

Help us advance kidney health worldwide
Join the ISN Subscribe to ISN Newsletter
Back to News